Active Ingredient(s):Besifloxacin FDA Approved: * May 28, 2009 Pharm Company: *BAUSCH AND LOMB Category:Vision / Eye Health
Besifloxacin (INN/USAN) is a fourth-generation fluoroquinolone antibiotic. The marketed compound is besifloxacin hydrochloride.
It was developed by SSP Co. Ltd., Japan, and designated SS734. SSP licensed U.S. and European rights to SS734 for ophthalmic use to InSite Vision Incorporated (OTC Pink: INSV) in 2000. InSite Vision developed an eye drop formulation (ISV-403) and conducted preliminary clinical trials before selling the product and all rights to Bausch & Lomb in 2003.[1&am...
* May have multiple approval dates, manufacturers, or labelers.